medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 01

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (01)

Genital skin carcinomas treated with Mohs micrographic surgery

Milena AE, Magliano J, Bazzano C

Language: Spanish
References: 20
Page: 71-76
PDF size: 221.14 Kb.


ABSTRACT

Background: Despite the promising efficacy of Mohs micrographic surgery, only a few cases have been reported where it has been applied to treat anogenital carcinomas. The outstanding feature of this technique is the horizontal section of the entire tumor margins. The main advantages of this technique are the greater preservation of healthy tissue and lower recurrence rates.
Clinical cases: Three cases of genital carcinomas are reported: one basal cell carcinoma and two spinocell carcinomas in situ. The diagnosis was established with the biopsy; later on, Mohs’ micrographic surgery was performed, the outcomes were satisfactory and without recurrences during the follow-up.
Conclusions: Although Mohs’ micrographic surgery is indicated in patients with genital carcinomas, there are few publications on its application in this context, despite controlling the entire margins of the lesion and being the technique that sacrifices the least amount of healthy tissue in an area where the tissue is highly valued for its anatomical characteristics.


REFERENCES

  1. Trofymenko O, et al. Melanoma of the face and Mohs micrographic surgery: Nationwide mortality data analysis. Dermatol Surg of Publ Am Soc Dermatol Surg Al. 2018; 44 (4): 481-92. doi. 10.1097/DSS.0000000000001429.

  2. Sharma AN, et al. Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma - a systematic review. J Dermatol Treat. 2019; 1-7. https://doi.org/10.10 80/09546634.2019.1690624.

  3. Aerts L, et al. Sexual, psychological, and relational functioning in women after surgical treatment for vulvar malignancy: a literature review. J Sex Med. 2012; 9(2):361-71. https://doi.org/10.1111/j.1743-6109.2011.02520.x.

  4. Lui PCW, et al. Vulvar basal cell carcinoma in China: a 13- year review. Am J Obstet Gynecol. 2009; 200 (5): 514.e1-5. https://doi.org/10.1016/j.ajog.2008.12.004.

  5. Casado-Verrier B, et al. Mohs micrographic surgery for verrucous carcinoma of the anogenital area: report of two cases. Int J Dermatol. 2012; 51 (6): 722-5. https://doi. org/10.1111/j.1365-4632.2011.05339.x.

  6. Siegel RL, et al. Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67 (1): 7-30. doi. 10.3322/caac.21387.

  7. Joura EA, et al. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med. agosto de 2000; 45 (8): 613-5.

  8. Tratamiento del cáncer de vulva (PDQ). Versión para profesionales de la salud. National Cancer Institute. 1980 https://www.cancer.gov/espanol/tipos/vulva/pro/ tratamiento-vulva-pdq.

  9. Weinberg D, et al. Vulvarcancer. Obstet Gynecol Clin North Am. 2019; 46 (1): 125-35. 10.1016/j.ogc.2018.09.008.

  10. Renati S, et al. Basal cell carcinoma of the vulva: a case report and systematic review of the literature. Int J Dermatol. 2018; https://doi.org/10.1111/ijd.14307.

  11. Jacobs GH, et al. Prediction of aggressive behavior in basal cell carcinoma. Cancer. 1982; 49 (3): 533-7. https:// doi.org/10.1002/1097-0142(19820201)49:3<533::AIDCNCR2820490322> 3.0.CO;2-O.

  12. Asuman C, et al. An unusual location of basal cell carcinoma: the clitoris and the vulva. Indian J Dermatol. 2008; 53 (4): 192-4. 10.4103/0019-5154.44795.

  13. Benedet JL, et al. Basal cell carcinoma of the vulva: clinical features and treatment results in 28 patients. Obstet Gynecol. 1997; 90 (5): 765-8. https://doi.org/10.1016/ S0029-7844(97)00416-X.

  14. Amavi AK, et al. Surgical management for squamous cell carcinoma of vulva. Pan Afr Med J. 2016; 24: 145. 10.11604/pamj.2016.24.145.8485.

  15. Iwasawa A, et al. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol. 1997; 89 (1): 81-4. https://doi.org/10.1016/ S0029-7844(96)00376-6.

  16. Al-Ghamdi A, et al. Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol. 2002; 84 (1): 94-101. https://doi.org/10.1006/ gyno.2001.6466.

  17. Coronado Martín PJ, et al. La inmunosupresión es un factor mayor de riesgo en la recidiva de las lesiones del tracto genital inferior asociadas al virus del papiloma humano. Prog Obstet Ginecol. 2010; 53 (5): 179-88. https://doi. org/10.1016/j.pog.2009.12.002.

  18. an Seters M, et al. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol. 2005; 97 (2): 645-51.

  19. Modesitt SC, et al. Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence. Obstet Gynecol. 1998; 92 (6): 962-6.

  20. AAD - Mohs micrographic surgery. Choosing Wisely. http://www.choosingwisely.org/clinician-lists/americanacademy- dermatology-mohs-micrographic-surgeryuncomplicated- melanoma.




2020     |     www.medigraphic.com